Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.
| Image |  |
|---|---|
| Description | scientific article published on 23 February 2015 |
| Author/s |
author: Keith Fox Philip Aylward Marc S Sabatine Philippe Gabriel Steg Pierre Theroux |
| Publication date | February 23, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |